Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2014

Open Access 01-05-2014 | Poster presentation

Barasertib: a novel approach for the treatment of metastatic melanoma

Authors: Amalia Azzariti, Letizia Porcelli, Anna Elisa Quatrale, Letizia Sidella, RM Iacobazzi, Gabriella Guida, Immacolata Maida, Tiziana Cocco, Anna Ferretta, Sabino Strippoli, Stefania Giuda, Stefani Tommasi, Angelo Paradiso, Michele Guida

Published in: Journal of Translational Medicine | Special Issue 1/2014

Login to get access

Excerpt

Metastatic melanoma represents the most deadly form of skin cancer. The poor response to chemotherapy and the brief response to the anti-BRAF vemurafenib in selected population of patients, make the identification of new therapeutic approaches an urgent need. Our goal is the evaluation of the efficacy of barasertib, an aurora B kinase inhibitor impairing cytokinesis, in both mutated and non-mutated melanoma cell lines. …
Metadata
Title
Barasertib: a novel approach for the treatment of metastatic melanoma
Authors
Amalia Azzariti
Letizia Porcelli
Anna Elisa Quatrale
Letizia Sidella
RM Iacobazzi
Gabriella Guida
Immacolata Maida
Tiziana Cocco
Anna Ferretta
Sabino Strippoli
Stefania Giuda
Stefani Tommasi
Angelo Paradiso
Michele Guida
Publication date
01-05-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue Special Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-S1-P7

Other articles of this Special Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue

Oral presentation

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma

Poster presentation

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab

Oral presentation

Harnessing host innate immunity may combat acquired resistance to BRAFi

Poster presentation

Enrichment of KIR+CD57+ highly cytotoxic NK cells in sentinel lymph nodes of melanoma patients

Poster presentation

In vivo targeting of cutaneous melanoma using an MSH-engineered human protein cage bearing fluorophore and MRI tracers

Oral presentation

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits